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Abstract
Objective
Design of bioactive scaffolds with osteogenic capacity is a central challenge in cell-based patient-specific bone
tissue engineering. Efficient and spatially uniform seeding of (stem) cells onto such constructs is vital to attain
functional tissues. Herein we developed heparin functionalized collagen gels supported by 3D
printed bioceramic scaffolds, as bone extracellular matrix (ECM)-mimetic matrices. These matrices were
designed to enhance cell seeding efficiency of mesenchymal stem cells (MSCs) as well as improve their
osteogenic differentiation through immobilized bone morphogenic protein 2 (BMP2) to be used for
personalized bone regeneration.

Methods
A 3D gel based on heparin-conjugated collagen matrix capable of immobilizing recombinant human bone
morphogenic protein 2 (BMP2) was synthesized. Isolated dental pulp Mesenchymal stem cells (MSCs) were then
encapsulated into the bone ECM microenvironment to efficiently and uniformly seed a bioactive ceramic-based
scaffold fabricated using additive manufacturing technique. The designed 3D cell-laden constructs were
comprehensively investigated trough in vitro assays and in vivo study.

Results
In-depth rheological characterizations of heparin-conjugated collagen gel revealed that elasticity of the matrix is
significantly improved compared with freely incorporated heparin. Investigation of the MSCs laden collagenheparin hydrogels revealed their capability to provide spatiotemporal bioavailability of BMP2 while suppressing
the matrix contraction over time. The in vivo histology and real-time polymerase chain reaction (qPCR) analysis
showed that the designed construct supported the osteogenic differentiation of MSCs and induced the
ectopic bone formation in rat model.

Significance
The presented hybrid constructs combine bone ECM chemical cues with mechanical function providing an ideal
3D microenvironment for patient-specific bone tissue engineering and cell therapy applications. The

implemented methodology in design of ECM-mimetic 3D matrix capable of immobilizing BMP2 to improve
seeding efficiency of customized scaffolds can be exploited for other bioactive molecules.
Graphical abstract

Keywords
Bone tissue engineering, ECM-mimetic, 3D printing, in situ seeding, Bone morphogenic protein 2, Injectable
thermogel

1. Introduction
Regeneration of critical-sized bone defects needs clinical interventions in most cases in order to restore,
maintain or improve the bone function [[1], [2], [3]]. Bone tissue engineering (BTE) techniques are introduced to
eliminate the pitfalls of bone grafts, which relies on delivery or recruitment of cells and bioactive agents through
three dimensional (3D) scaffolds. Over the past years, 3D printing techniques have shown great potential to
fabricate customized scaffolds with complex geometries and controlled pore structure [[4], [5], [6], [7]]
An ideal scaffold should not only support the complex geometries of bone defects to guide the bone tissue
regeneration, but also provide a porous microenvironment to recruit biologics and regulate cellular growth and
differentiation [8,9]. However, generation of cell-seeded implantable 3D scaffold is still remained problematic
due to the low cell seeding efficiency and deficient cellular distribution [10]. To enhance cell delivery to the
defect, encapsulation of regenerative cells into the external matrix has been
proposed. Biomimetic hydrogels have shown promising capabilities to meet the demands for cell delivery, local,
and sustained release of growth factors [11,12]. In addition to the capability of hydrogels to provide cells
anchorage, chemical cues, proper viscoelasticity and stiffness are essential for viability and fate of the
encapsulated cells [[13], [14], [15], [16]].
Collagen as the main component of the native ECM has been widely used as an appropriate biomaterial for cell
encapsulation due to its favorable biocompatibility, degradation, and tissue regeneration potential properties
[4,17]. Encapsulation of MSCs within injectable collagen has demonstrated not only preservation of cells’
differentiation potential, but also cell viability upon in vivo implantation [18]. Despite favorable characteristics of
collagen hydrogels, the shortcomings of gel-like collagen matrices including matrix contraction and low
mechanical properties impede their application for hard tissue engineering [19].
There has been a great deal of interest in using mesenchymal stem cells (MSCs) for bone regeneration owing to
their ability to provide osteoinductive bone factors and differentiation to osteoblasts in vitro and in vivo [20,21].

It has been reported that engineering of bone tissue with enriched delivery of MSCs is a promising approach to
improve the regeneration [22].
In this view, forming MSCs laden collagen matrices within supportive mineral-based 3D printed scaffolds
promises an ideal biomimetic approach through harvesting the advantages of hydrogel-mediated efficient cell
delivery and mechanically robust scaffold. Several evidences have shown that MSCs engineered with bone
morphogenetic protein 2 (BMP2) more effectively induced bone formation than MSC implantation alone in both
ectopic and orthotopic sites. Bone morphogenetic protein2 (BMP2) has been confirmed to promote osteogenic
differentiation of mesenchymal stem cells (MSCs) as well as ectopic bone formation [23,24]. In native
ECM, BMP2 exist in soluble as well as in matrix-bound forms [25,26]. Although rhBMP2 has successfully been
administered clinically through collagen-based carriers to stimulate bone regeneration, a high dose of rhBMP2 is
required, likely due to its short half-life in vivo [27,28]. Several studies demonstrated that bound growth factor
to the ECM conveys signaling by prolonged activation of receptors and differential phosphorylation [24]. The
major advantage of growth factor immobilization is improved efficiency, i.e., a small amount, and controlled
presentation of the molecule [29]. The distinct biocharacteristics of glycosaminogycans (GAGs) like heparan
sulfate, make them valuable biomolecules for binding and modulation of growth factors, and ECM proteins
[[30], [31], [32]]. It has been reported that incorporation of GAGs into different hydrogel matrices is potentially
beneficial to achieve immobilization and sustained bioavailability of rhBMP2 [33,34].
Herein a reinforced hybrid construct has been developed to mimic natural bone ECM. The heterophasic
constructs consisted of a 3D collagen-based matrix encapsulating cells, which is mechanically supported by a
reinforced ceramic scaffold (Scheme 1). The ceramic scaffold, as the mineral phase of the constructs, was
composed of β-TCP nanoparticles and fabricated using the 3D printing technique. The 3D microenvironment for
cellular activity was synthesized based on heparin immobilized collagen gel-like matrices with capability of
providing sustained bioavailability of rhBMP2. The collagen matrix was chemically functionalized with heparin to
not only provide binding of rhBMP2, but also control the contraction of the cell-laden matrix. Mesenchymal
stem cells were encapsulated into the bone ECM-mimetic collagen-based matrices.

Scheme 1. The schematic representation of the developed approach to enhance in situ seeding and osteogenesis of MSCs
on 3D printed scaffold through injectable BMP2 immobilized Collagen Heparin gel.

2. Methods and materials
2.1. Design and characterization of ECM mimetic collagen-heparin (Col-Hep) matrix
2.1.1. Synthesis of heparin conjugated collagen
The collagen matrix was modified through chemical functionalization with heparin (Hep) in order to achieve
binding domains for the growth factor, which is described below. The carboxyl groups of Hep were
activated via carbodiimide chemistry prior to reaction with collagen chains. In brief, 5 mg heparin sodium salt
(Alfa Aesar) was activated with 10 mg 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC, TCI
Chemicals) and 6 mg N-hydroxysuccinimide (NHS, Alfa Aesar) in 2.5 ml 0.05 M 2-[N-Morpholino] ethanesulfonic
acid (MES, MP Biomedicals) solution for 10 min at 37 °C. The activated heparin solution was dialyzed through a
dialysis membrane (Spectra/Por®, MWCO: 3.5–5 kD) with 500 ml water for one day to remove excess EDC/NHS.
Afterward, the activated heparin solution was precipitated, and then kept overnight at −80 °C. The samples were
freeze-dried at 1 Pa and −52 °C for 24 h followed by overnight secondary drying at room temperature and 1 Pa.
The free heparin and activated heparin solution were added at various concentrations (50 and 100 μg ml−1) to
the collagen solution (Bovine collagen type I, Advanced BioMatrix). The ECM mimetic collagen-heparin (Col-Hep)
matrices were prepared by mixing the collagen solution at 4 °C with 10× concentrated Dulbecco's Modified Eagle
Medium (DMEM) and Hank's Balanced Salt Solution (HBSS) to achieve 2.5 mg ml−1 for collagen content and then
neutralized to pH 7.4 using 1N NaOH. After being well mixed, the collagen-based solutions were incubated at
37 °C for 30 min for gelification.
The conjugation efficiency of heparin onto collagen matrices was analysed using the toluidine blue assay. The
conjugation efficiency was carried out at room temperature with distilled water as the release medium under
gentle stirring. 2 ml of released solution was thoroughly mixed with 3 ml of toluidine blue solution (2 mg of
toluidine blue, 230 mg NaCl in 250 ml 0.01 M hydrochloric acid). 3 ml of n-hexane was then added, and the
mixture was shaken well in order to extract the heparin into the organic layer. Finally, the absorbance of the
aqueous phase was measured at different time intervals using a spectrophotometer (Thermo Scientific™
Evolution™ 220 UV–vis Spectrophotometer) at 631 nm [35].

2.1.2. Characterization of col-hep matrices
2.1.2.1. Physicochemical characterization of col-hep matrices
The microstructural changes in collagen matrices after functionalization with activated heparin chains were
examined by scanning electron microscopy (SEM; JEOL JSM-6510LV). The denaturation behavior of collagen
chains in freeze-dried Col-Hep sample was investigated by differential scanning calorimetry method (DSC;
NETZSCH DSC 404 F1 Pegasus®), and compared with that of for pristine collagen. DSC measurements were
carried out on 5 mg sample in aluminum crucibles with pierced lid under 20 ml min−1 ultra-pure argon ﬂow. In
order to ensure the samples were fully dried, the crucibles were heated to 130 °C, incubated for 30 min, and
then heated to 250 °C at a 10 °C min−1 heating rate. The chemical structure of Col-Hep matrices was examined
using the Fourier-transform infrared spectroscopy method (FT-IR; Nicolet™ iS5, iD5 Diamond Attenuated total
reflection, Thermo Scientific™) [36].
2.1.2.2. Rheological measurements of collagen-based matrices
Oscillatory shear measurements were performed by means of a Malvern Kinexus pro + rheometer using a coneand-plate geometry (diameter: 40 mm, cone angle: 4°). After loading samples, the cone and plate were covered
to avoid sample dehydration. Strain amplitude of 1% was applied to minimize the network perturbation during
measurements. Prior to temperature sweep measurements at different frequencies, the strain amplitude sweep
measurement was performed to ensure the measurements were conducted in the linear viscoelastic regime and
the viscoelastic features (dynamic storage modulus G′ and loss modulus G″) are independent of the strain
amplitude [13,37]. The oscillatory frequency sweep measurements were carried out over the angular frequency

(ω) interval of 0.1–10 rad/s, while the temperature was increased with a heating rate of 1 K min−1. The time
sweep measurements were performed at 37 °C, strain amplitude of 1%, and frequency of 1 rad s−1 for 150 min.

2.1.3. Matrix contraction assay
The collagen-based gel-like matrices (Col and Col-Hep) were prepared as described above. Subsequently, the
resultant solution was mixed with 1 × 106 MC3T3. The obtained constructs were kept at room temperature for
30 min, and then placed in an incubator under a humidified atmosphere of 5% CO2 in air at 37 °C. The
contraction of collagen-based gel-like matrices was measured in triplicate. The matrix contraction was measured
at various time intervals of 12, 24, 48, and 72 h [38].

2.1.4. Immobilization of rhBMP2 and in vitro release profiles
Five μg rhBMP2 (Cell Applications, Inc) was mixed with the collagen-based solutions (Col and Col-Hep) prior to
gelification according to the procedure described above. Col and Col-Hep matrices were then incubated
in phosphate buffered saline (PBS; 120 mM NaCl, 2.7 mM KCl, 10 mM phosphate buffer salts), and after 4 h,
100 μl samples of the supernatant were collected to measure the rhBMP2 washout. The samples withdrawn for
analysis were then replaced with the same volume of fresh medium. The in vitro release of rhBMP2 from Col and
Col-Hep matrices was evaluated in PBS buffer solution according to a similar procedure at scheduled time
intervals of 1, 3, 7, 14 and 21 days. The collected samples were centrifuged at 5000 rpm at room temperature
and the supernatant was analyzed for rhBMP2 content via ELISA kit (Cell Applications, Inc.). The concentration of
rhBMP2 was calculated in ng ml−1 of the solution.

2.1.5. BMP2 bioactivity assay
The viability of MC3T3 cells [39] encapsulated into collagen-based matrices were evaluated using LIVE/DEAD cell
viability assays (Thermo Fisher Scientific) at days 3 and 7. In brief, cell-laden matrices were washed with sterile
PBS three times for 10 min and then incubated for 1 h with 4 mM calcein-AM and 4 mM ethidium homodimer in
PBS at room temperature. After incubation, matrices were washed again for fluorescence microscopy (EVOS FL
Auto Cell Imaging System, Thermo Fisher Scientific). The bioactivity of BMP2 was assessed utilizing an
Alkaline Phosphatase (APase) Assay Kit based on a colorimetric assay kit (Abcam, USA). The APase activity of
MC3T3 cells when encapsulated into the Col-Hep, Col/rhBMP2 and Col-Hep-rhBMP2 matrices was assessed after
7 and 14 days according to the manufactures protocol. In brief, the cells were digested, collected, and lysed.
Subsequently, 30 μl samples from lysate was added to a 96-well plate with 50 μl of the assay buffer and 50 μl of
pNPP. The samples were covered and incubated at room temperature for 1 h. Subsequently, 20 μl of stop
solution (3 N NaOH) was added to the wells, and the absorbance of p-nitrophenol was measured at 405 nm
using a microplate spectrophotometer (Synergy™ HTX Multi-Mode Microplate Reader, Bio-Tek Instrument). Cell
lysates were also analyzed for protein content using a micro-BCA Assay kit (Pierce), and ALP activity was
normalized to the total protein content, which was measured using Pierce BCA protein assay kit (Thermo Fisher
Scientific). Alkaline phosphatase activity is expressed in arbitrary units. The results represent the mean values of
three individual experiments and each in quadruplicate.

2.2. Fabrication and characterization of 3D printed β-TCP scaffolds
2.2.1. 3D printing of β-TCP scaffolds
The ceramic based paste ink formulation was composed of 75wt.% beta-tricalcium phosphate powder (β-TCP,
Sigma), 0.35wt.% carboxymethylcellulose (CMC, Alfa Aesar) as the binder, 2.5wt% sodium tripolyphospahte
(TPP, Alfa Aesar) as the viscosity modifier, and 5wt.% colloidal silica nanoparticles (cSiO2, LUDOX®, Sigma) as the
high temperature binder. The paste components were mixed in aqueous medium using a planetary centrifugal
mixer (THINKY Mixer, ARE-310). Carboxymethyl cellulose (CMC) is an organic binder that have been widely used
in ceramic shaping to enhance the performance of bodies during process and applications. It has been reported
that CMC improve the mechanical strength of dry bodies and completely burn out during firing. Prior to printing,

the temperature of the paste reservoir was set to 20 °C for 10 min. The formulated pastes were then injected
out of the nozzle by air flow to layer-by-layer fabricate disk-shaped (7 mm diameter and 2 mm thickness) porous
scaffolds based on pre-designed models with CAD/CAM software. Scaffolds were consisted of 10 printed layers
in total. The 3D printing process was performed at 3 mm/s dispensing speed, optimal pressure of 1.2 bar, and a
plotting needle (Nordson, USA) with an inner diameter of 400 μ m (Table 1). The scaffolds were printed with
600–800 μm distance between strands and a 90° shift between layers. Scaffolds were air dried at room
temperature overnight, sintered in a furnace (KSL-1700X-S-UL, MTI) at 600 °C for 1 h, and then at 1100 °C for 4 h.
Table 1. 3D printing parameters.
Ceramic paste temperature
Platform temperature
Pressure
Speed
Distance between strands
Slice width

20 °C
RT
1.2 bar
3 mm/s
600–800 μm
150 μm

2.2.2. Characterization of β-TCP scaffolds
The 3D printed scaffolds were characterized by their microstructure (pore size and thickness of strands) using a
3D Laser Measuring Microscope (Olympus LEXT OLS 4000, Japan). The mechanical properties of β-TCP-based
scaffolds were measured according to ASTM standards using in compression mode using a universal testing
machine (AGS-X series, 5 kN load cell, Shimadzu, Japan) at a speed of 1 mm min−1. The porosity of scaffold was
quantified using previously reported solvent displacement method [20]. For this purpose, the weight of scaffolds
was measured in dry condition and immersed in 10 ml ethanol, then the porosity was analysed using the
following equation:Porosity=Ww-Wd×100%ρ×πR2T
In which ρ is the solvent density, Wd and Ww are the weight of scaffold in dry and wet condition, and R, T are
the radius and thickness of scaffolds, respectively.
At least three sintered cylindrical samples (5 mm diameter, 10 mm height) were compressed until they cracked.
Elastic moduli were derived from the initial linear region of the stress-strain curves.

2.2.3. Dental pulp mesenchymal stem cells seeding strategies
Dental pulp mesenchymal stem cells (MSCs) were isolated as described elsewhere [4]. In brief, normal
impacted third molars were first washed in PBS containing 100 U ml−1 penicillin and
100 mg ml−1 streptomycin (GIBCO, Invitrogen Corporation). After cutting the crown, the pulp tissue was
removed. In the next step, the pulp tissue was digested using a solution comprising 3 mg ml−1 collagenases type I
(Alfa Aesar) and 4 mg ml−1 dispase (Sigma) in Hank’s Balanced Salt Solution (HBSS, Sigma) for 1 h at 37 °C with
regular agitation. The digested mixture was added to alpha-minimal essential medium (α-MEM, Sigma)
supplemented with 15% fetal bovine serum (FBS, Sigma), seeded in culture dishes and incubated in 5% CO2 at
37 °C. The expression of cell-surface markers of dental pulp cells was determined by the fluorescence activated
cell sorting (FACS) technique (Attune® Acoustic Focusing Cytometer, Thermo Fisher Scientific). In order to verify
the osteogenic capability of the cells, the alizarin red assay was carried out. In brief, the extracted cells at
passage 3 were cultured on tissue culture polystyrene for 3 weeks in an osteogenic medium, consisting of
αMEM supplemented with 10% FBS, 50 μg/ml ascorbic acid, 10 mM β-glycerophosphate and
10 nM dexamethasone. Then, the samples were fixed, washed and stained with alizarin solution (Alfa Aesar).
Prior to in vitro cell culture studies, the disk-shaped 3D printed scaffolds were disinfected using 70wt.% aqueous
ethanol solution. The disinfection process included three times immersion in 70% ethanol for 15 min followed by

rinsing with PBS cycles and air drying. Afterward, 1 × 106 cells were seeded on the scaffold through two
approaches. (1) MSCs were directly seeded onto the scaffolds which were placed in a non-adherent 12 wellplate and then submerged in culture medium. The medium was changed every other day; (2) MSCs were loaded
through cell-laden thermogels and then added to the construct on the ice and then the constructs were
incubated in 37C to solidify the gel.
For PrestoBlue® cell vitality, after the incubation period, 10% Presto blue was added to the scaffold-cell
complexes. Fluorescence measurements (Ex: 560 nm and Em: 590 nm) were determined by a
spectrophotometric plate reader (Synergy HTX, BioTEK). The alkaline phosphatase (APase) activity was
measured based on a colorimetric assay kit using p-nitrophenyl phosphate (pNPP) as a phosphatase substrate
(Abcam, USA). Triplicate samples were analyzed for this experiment. PrestoBlue® cell vitality assay (Thermo
Fisher Scientific) and APase Activity (Abcam, USA) was performed according to the manufacturer’s instructions
after 3, 7 and 14 days of cell culture on scaffolds.

2.3. Characterization of reinforced collagen-based matrices
2.3.1. Cell seeding efficiency and cell adhesion
Cell seeding efficiency was analysed as described elsewhere [40]. In brief, the cells were loaded onto the
scaffolds which were placed in a non-adherent 6 wells plate and incubated for 12 h in 5% CO2 at 37 °C. Then, the
scaffolds were removed and the number of remaining cells in the wells was measured using a counting chamber
method. Considering the number of loaded cells, the seeding efficiency was calculated using the following
equation,Cellseedingefficiency(%)=cellsloadedonscaffold-residualcellsinwellscellsloadedonthescaffold×100
The reinforced cell-laden collagen-based gel-like matrices, βTCP/Col, βTCP/Col-Hep and βTCP/Col-Hep-BMP2
constructs, were characterized using scanning electron microscopy. In brief, the scaffolds were removed from
the culture medium after predetermined incubation times, washed in PBS, fixed with Karnovsky's Fixative, and
then dehydrated in gradient aqueous ethanol solutions of 50, 60, 70, 80, 90 and 100%. Samples were gold
sputter coated using a GSL-1100X-SPC12 Compact Plasma Sputtering Coater instrument, and then scanned by
the scanning electron microscope (JEOL JSM-6510LV).

2.3.2. Cell proliferation
In order to examine the cell proliferation in βTCP/Col, βTCP/Col-Hep and βTCP/Col-Hep-rhBMP2 constructs
aDNA quantification assay was conducted at 3, 7, 14 and 21 days. The DNA quantification was carried out by
means of the Quant-iT™ PicoGreen® dsDNA Assay Kit (Thermo Fisher Scientific) following the manufacturer’s
protocol. In Brief, constructs were first digested in 1 ml of 4 M guanidine hydrochloride buffer (pH = 7.5).
Afterward, 50 μl of samples or DNA standards were incubated with 150 μl of 1 × PicoGreen reagents. Finally,
fluorescence measurements (Ex 480 nm/Em 520 nm) were performed by a spectrophotometric plate reader
(Synergy™ HTX Multi-Mode Microplate Reader, Bio-Tek Instrument).

2.3.3. Cell differentiation
APase activity, immunocytochemistry, and Quantitative real-time polymerase chain reaction(qPCR) were
performed to assess the MSCs differentiation. The Alkaline Phosphatase Assay Kit (Abcam) was used according
to the manufactures protocol.
For osteocalcin (OCN) immunocytochemistry, the samples were first fixed with 4% paraformaldehyde and then
permeabilized. Afterward, the samples were incubated in primary osteocalcin antibody (1:100) and
subsequently in anti-rabbit antibody Alexa Fluor 647 (Abcam). The cells nuclei were then stained using DAPI.
In order to perform qPCR assay, the scaffolds (n = 6) were collected at days 7 and 14, then pulverized. Total RNA
was extracted using Trizol reagent (Invitrogen) following the instructions provided. RNA (1 μg) was used to

reverse transcribed into complementary DNA (cDNA) (Invitrogen). For the polymerase chain reaction (PCR),
aliquots of synthesized cDNA were added to SYBR® Green PCR Master Mix (Applied Biosystems, USA) and cycled
on a DNA thermal cycler. Primers for PCR were as follows: 1) Alkaline phosphatase (ALP) fwd 5′ACGTGGCTAAGAATGTCATC-3′, rev: 5′-CTGGTAGGCGATGTCCTTA-3′, 2) Osteocalcin (OCN) fwd: 5′CATGAGAGCCCTCACA-3′ rev: 5′-AGAGCGACACCCTAGAC-3′, 3) Runt-related transcription factor 2 (RUNX II) fwd:
5′-TCTTCACAAATCCTCCCC-3′ rev: 5′-TGGATTAAAAGGACTTGG-3′, 4) β-ACTIN fwd: 5′-AGCCATGTACGTTGCTA-3′
rev: 5′-AGTCCGCCTAGAAGCA-3′. All experiments were performed in triplicate.

2.4. Subcutaneous implantation of constructs
For this study, Male Fischer 344 rats with age: 7–8-week-old were used in our animal study based on a protocol
approved by the Institutional Animal Care and Use Committee (IACUC) of Marquette University. The rats were
housed in a temperature and humidity-controlled environment on a 12/12 h light/dark cycle, with food and
water made available ad libitum. 5 × 106 MSCs were encapsulated in heparin conjugated collagen hydrogels,
heparin conjugated collagen hydrogels immobilized with 25 μg/ml rhBMP2 or collagen hydrogels containing
25 μg/ml rhBMP2. The disk-like MSC-scaffolds with 7 (diameter)×2(thickness) mm dimension were
subcutaneously implanted into the dorsum of animals. The constructs without rhBMP2 were used as negative
controls. Five animals (n = 5) in each group were used with two transplants in each. The implanted MSCs were
harvested six weeks post-surgery. For histological tissue processing, harvested samples were fixed in 4% para
formaldehyde (PFA) for 24 h and decalcified in 10% EDTA at 4 °C for 6 weeks. Samples were then dehydrated in
ethanol and embedded in paraffin. Sections (5 μm) were cut using a microtome. The slides were then
deparaffinized and rehydrated in a graded ethanol series (100%, 90%, and 70% ethanol, 5 min each; dH2O for
10 min) before being stained with hematoxylin and eosin (H & E). In order to perform qPCR assay, tissue was
collected after 6 weeks, then pulverized (n = 4). The total RNA was extracted using Trizol reagent (Invitrogen),
following the instructions provided. RNA (1 μg) was used to reverse transcribed into complementary DNA
(cDNA) (Invitrogen). For the polymerase chain reaction (PCR), aliquots of synthesized cDNA were added to with
SYBR® Green PCR Master Mix (Applied Biosystems, USA) and cycled on a DNA thermal cycler. All experiments
were performed in triplicate.

2.5. Statistical analysis
All data were expressed as mean ± standard deviation (Mean ± SD). The significance difference was calculated by
one-way ANOVA complemented by Tukey's multiple comparisons test. P-values < 0.05 were considered to be
statistically significant.

3. Results
3.1. ECM mimetic heparin conjugated collagen matrices
The structural stability of heparin in collagen matrix incorporated either using preactivated
by carbodiimide reaction or simple mixing was measured based on Hep release over 7 h at physiological pH
(7.4). As shown in Fig. 1A, 51.9 ± 4.1% of the 50 μg ml−1 simply mixed Hep was released after 7 h incubation,
while just 16.3 ± 2.9% of the corresponding chemically activated Hep was washed out over the same time
interval. Although the amount of immobilized Hep enhanced with increasing its concentration to 100 μg ml−1,
but also led to rapid polymerization of the neutralized collagen. In this view, Hep-conjugated collagen at
50 μg ml−1 concentration, denoted as Col-Hep was selected for further characterizations.
The freeze-dried Col and Col-Hep matrices were characterized for their microstructure using scanning electron
microscopy. As depicted in Fig. 1B–C, the Hep-Col matrix possess locally tighter microstructures likely due to Hep
bound microdomains, while the collagen fibrils are more uniformly distributed into the pristine Col matrix. In the

case of Col-Hep matrix, the Hep chains bind to the amino groups of collagen through their activated carboxyl
groups, which have resulted in bundled fibrils in variable arrangements.

Fig. 1. (A) The release pattern of heparin incorporated in different forms (free and activated at 50 or 100 ng ml −1) from
various collagen-based matrices (Col and Col-Hep) at physiological condition (pH7.4, 37 °C). Scanning electron micrograph
of (B) Col, and (C) Col-Hep matrix (scale bar is 100 μm). (D) Differential scanning calorimetry thermograms of freeze-dried
Col and Col-Hep matrices. (E) Fourier transform infrared spectra of Col, and Col-Hep matrices. (F) The storage modulus (G'),
(G) loss modulus (G″), and (H) complex viscosity as a function of time at 37 °C.

In order to examine the effect of Hep conjugation on denaturation temperature of collagen chains, Col and ColHep matrices were studied by means of differential scanning calorimetry (Fig. 1D). The observed peaks are
associated with the denaturation of collagen. The onset and denaturation temperatures were measured as
169.6 and 194.1 °C for Col, where shifted to higher temperatures of 205.4 and 224.8 °C for Col-Hep, respectively.
The FT-IR spectra of freeze-dried Col and Col-Hep matrices are shown in Fig. 1E. In Col spectrum, a broad band
associated with amine and carboxyl groups is observed around 3320 cm−1. The band at 1403 cm−1 is associated
with symmetric stretching vibrations of the carboxylate anions. As can be seen in the spectra, it is evident that
Col-Hep sample show lower intensities for carboxyl and amine relevant bands in comparison with Col matrix,
which corroborates conjugation of Hep chains onto the Col matrix.
Fig. 1F–H shows the evolution of the complex viscosity for Col, Col/FreeHep, and Col-Hep matrices with its
absolute value |η*(ω)| given by η*(ω)=(G'2+G''2) 1/2/ω, where G' and G” are the storage and loss modulus,
respectively. A Similar trend of G' was observed for the complex viscosity. As seen, the complex viscosity for ColHep is raising with time, while for Col and Col/FreeHep complex viscosity was found to decrease after reaching a
maximum value. Viscoelastic properties of collagen and Col-Hep matrices were studied based on oscillatory
sweep rheological measurements. Thermal evolution of the storage modulus for Col and Col-Hep solutions in
the course of gelification are displayed in Fig. 2A and B, respectively. As seen, G' for both Col and Col-Hep
matrices is increasing with raising temperature over the whole temperature range up to 40 °C, while decreases
at temperatures beyond. G′ was found to be higher for Col-Hep compared to Col matrix over the whole studied
temperature range. The loss modulus for Col and Col-Hep matrices at various temperatures in the course of
gelification is displayed in Fig. 2C and D, respectively. As shown, a similar trend as that of for storage modulus is

observed. Fig. 2E and F displays the temperature-induced evolution of the viscoelastic damping factor (tanδ) for
Col and Col-Hep matrices. According to the methodology developed by Chambon and Winter [41], the gel point
is determined based on a frequency-independent value of loss tangent (tan δ = G”/G') obtained from a multifrequency plot of tanδ versus temperature [13]. As displayed in Fig. 2E and F, the neutralized Col and Col-Hep
solutions to the pH 7.4 does not show gelation behavior from a rheology point of view, but viscosification
because of corresponding associations. We observed that the inclusion of activated Hep chains into the Col
matrix strengthen the corresponding associations. Fig. 2E and F illustrate tanδ for Col and Col-Hep matrices is
decreased with increasing temperature, which denotes gradual increase in elasticity of the matrices.

Fig. 2. Rheological characterization of Col and Col-Hep matrices: storage modulus (G′) as a function of temperature at the
indicated frequencies for (A) Col, and (B) Col-Hep matrices. Thermal evolution of the loss modulus (G″) for (C) Col, and (D)
Col-Hep matrices. Temperature-induced evolution of the viscoelastic loss tangent (tanδ) for (E) Col, and (F) Col-Hep
matrices.

The alterations in diameter of Col and Col-Hep matrices during 3 days incubation in culture plates are displayed
in Fig. 3A. The Col matrix showed considerably higher contraction compared with the Col-Hep matrix. The Col
matrix was found to contract to 47.9 ± 5.8% and 34.5 ± 3.8% of its initial diameter after 12 and 72 h, while ColHep matrices showed markedly lower contraction. The matrix contraction results revealed that Col-Hep reaches
to 76.2 ± 6.6 and 59.4 ± 6.1 of its initial diameter after 12 h and three days, respectively.

Fig. 3. (A) Matrix contraction for Col and Col-Hep matrices over three days. (B) The release pattern of rhBMP2 from Col and
Col-Hep matrices over three weeks (The inset shows the rhBMP2 washout from Col and Col-Hep matrices after 4 h).
Viability of MC3T3 encapsulated in Col-Hep matrix after (C) 3 days, and (D) 7 days. Viability of MC3T3 encapsulated in ColHep matrix comprising rhBMP2 after (E) 3 days, and (F) 7 days. (G) APase activity of 3D cultured MC3T3 in Col-Hep,
Col/rhBMP2, and Col-Hep-rhBMP2 matrices.

The determination of in vitro release profiles disclosed that the immobilization of Hep moieties into the collagen
matrix have effectively retarded the release kinetics of rhBMP2 over an extended period of time of three weeks
(Fig. 3B). Further, it was found that the amount of rhBMP2 washout is remarkably decreased from the Col-Hep
matrix. The inset shown in Fig. 3B exhibits Col-Hep matrix significantly reduced rhBMP2 washout to
91.5 ± 27.7 ng/ml in comparison with 438.4 ± 130.3 ng/ml for the Col matrix. The viability of MC3T3 cells
encapsulated in Col-Hep matrices comprising rhBMP2 was compared with the corresponding matrices in the
absence of rhBMP2. The results of live/dead staining shown in Fig. 3C-F present the viability and proliferation of
MC3T3 cells in the Col-Hep matrix over one week. As can be seen in Fig. 3E and F, the immobilization of rhBMP2
into the Col-Hep matrix increased the proliferation of MC3T3. It is worthy to note that the incorporated rhBMP2
into the Col matrix also provides increased MC3T3 cells proliferation though in a less pronounced manner.
Alkaline Phosphatase (APase) activity, as an early osteoblastic differentiation marker [42], was investigated to
evaluate the bioactivity of Col and Col-Hep matrices comprising rhBMP2. As can be seen in Fig. 3G, the Col-HeprhBMP2 matrix showed superior APase activity.

3.2. 3D printed βTCP based scaffolds
Tricalcium phosphate (TCP) based bioceramic scaffolds with reproducible microstructure were fabricated using
the additive layer manufacturing technique. The microstructure of the scaffolds was shown in Fig. 4 A, B. The
measured mean ± Standard deviation of pore size of the scaffolds was 497 ± 18 μm and 416 ± 23 μm before and
after sintering, respectively. The strand thickness was 514 ± 7 μm, and the porosity of scaffolds was 47.5 ± 3.4%.
The compressive strength of β-TCP based scaffolds was measured to be 10.82 ± 4.6 MPa. The compressive
modulus for the scaffolds was measured to be 85.9 ± 4.8 MPa.

Fig. 4. 3D laser scanning micrographs of the 3D-printed β-TCP scaffold (A, B), Scanning electron micrographs of (C), Col-Hep
and (D), Col-Hep-rhBMP2 matrices encapsulating MSCs filled into the 3D printed β-TCP scaffolds after 21 days (A, B: scale
bar is 500 μm).

3.3. Cell seeding strategies
The seeding efficacy of MSCs through the gels was 100%, however by directly seeding the MSCs on the 3D
printed scaffolds, the 21.75% of MSCs was attached to the scaffolds. The viability of MSc seeded directly on the
3D printed β-TCP scaffold was compared to MSCs laden constructs over two weeks. The results demonstrate
significantly improved proliferation of MSCs loaded into the gels and seeded on the constructs compared with
MSCs directly seeded on the β-TCP scaffold. The ALP expression of MSCs loaded into the gels and seeded on 3D
scaffolds was found to be significantly higher than the other group.

3.4. 3D Printed reinforced Col-Hep matrix
The SEM micrographs of Col-Hep and Col-Hep-rhBMP2 matrices encapsulating MSCs, which were supported by
the 3D printed β-TCP scaffolds are shown in Fig. 4C, D. As seen, the Fig. 5E, reinforced Col-Hep-rhBMP2 matrix
shows improved proliferation of 3D cultured MSCs. The DNA PicoGreen assay was used to assess the
combinatorial effects the triad key elements of scaffold, cells and the growth factor in Col/β-TCP, Col-Hep/β-TCP
and Col-Hep-rhBMP2/β-TCP constructs. MSCs proliferated in all three groups up to 21 days. Further, it was
found that the proliferation rate of MSCs was significantly higher in Col-Hep-rhBMP2/β-TCP constructs
compared to Col/β-TCP and Col-Hep/β-TCP after 3, 7, 14 and 21 days (P < 0.01). However, Col-Hep/β-TCP
showed a similar proliferation rate of encapsulated MSCs to Col/β-TCP over three weeks. Fig. 5F shows the
APase activity of Col/β-TCP, Col-Hep/β-TCP and Col-Hep-rhBMP2/β-TCP constructs to examine the effects of
combined scaffold, cells and growth factors. The highest APase activity was observed for the Col-Hep-rhBMP2/βTCP (P < 0.01). The APase activity of cells was found to increase for 21 days in all three groups. Col-HeprhBMP2/β-TCP construct showed significant greater cells proliferation rate and APase activity compared to
Col/β-TCP, Col-Hep/β-TCP constructs after 3, 7, 14 and 21 days. Fig. 5 A–D, shows the immunofluorescent
images of osteocalcin marker for encapsulated MSCs into Col-Hep and Col-Hep-rhBMP2 matrices supported by
the 3D printed β-TCP scaffolds after 14 and 21 days. The images demonstrate that OCN marker is higher in the
presence of rhBMP2 after 14 and 21 days. Quantitative real-time PCR analysis for RUNX-2, OCN and ALP of MSCs
cultured on β-TCP/Col-Hep and β-TCP/Col-Hep-rhBMP2 construct are presented in Fig. 5G–H. The qPCR analysis
showed that the mRNA expressions of RUNX-2, OCN and ALP were significantly higher in the immobilized

rhBMP2 group after 7 and 14 days (P < 0.01). The expressions of RUNX-2, OCN and ALP were upregulated 1.2
fold, 2.4 and 2.3 fold at day 14 (P < 0.01), respectively.

Fig. 5. (A-D) The immunofluorescent images of osteocalcin marker for encapsulated MSCs into β-TCP/Col-Hep and βTCP/Col-Hep-rhBMP2 matrices scaffolds after 21 days scale bar is 500 μm). (A-B) for β-TCP/Col-Hep, and (C-D) for βTCP/Col-Hep-rhBMP2. (E) DNA quantification of MSCs cultured β-TCP/Col, β-TCP/Col-Hep and β-TCP/Col-Hep-rhBMP2
constructs. (F) Alkaline phosphatase (APase) activity of MSCs cultured β-TCP/Col, β-TCP/Col-Hep and β-TCP/Col-HeprhBMP2 constructs. Quantitative real-time PCR analysis for RUNX-2, OCN and ALP of MSCs cultured β-TCP/Col-Hep and βTCP/Col-Hep-rhBMP2 constructs after 7 days (G) and 14 days (H).

3.5. Subcutaneous implantation of constructs
Regeneration was uneventful in all of the subcutaneous surgical sites. Neither severe inflammation nor foreign
body reaction was seen in any of the tissue evaluated (Fig. 6). In all constructs, the newly created tissue varied in
size, comprising of thin pieces of mineralized tissue and large marrow spaces with connective tissue cells and
occasional hematopoietic cells. Cuboidal osteoblast-like cells were found to be regenerating the constructs to
varying degrees along the mineralized tissue in all of the groups. More obvious findings of mineralized tissue
were often found in the βTCP/Col-BMP2 + MSCs and βTCP/Col-Hep BMP2+ MSCs scaffolds. Furthermore, direct
bone-biomaterial contact and new bone formation occurred to a greater degree in the βTCP/ColHep BMP2 + MSCs group. The RNA expression level of osteogenic related genes including RUNXII, OCN, and ALP,
were evaluated by qPCR and showed significant differences between the BMP2 containing groups, βTCP/ColBMP2 + MSCs and βTCP/Col-Hep BMP2 + MSCs, and control group without BMP2, βTCP/Col-Hep + MSCs, and
also between immobilized BMP2, βTCP/Col-Hep BMP2+ MSCs, and loaded BMP2 scaffold groups. Addition of
BMP2 in the form of immobilization leads to a significant increase in RNA expression toward osteogenesis.

Fig. 6. Hematoxylin and eosin staining of sections from decalcified scaffolds loaded with cells (A–C), βTCP/Col-Hep + MSCs
(D–F), βTCP/Col-BMP2 + MSCs and (G–I), βTCP/Col-Hep BMP2+ MSCs scaffolds after 6 weeks of subcutaneous implantation
(J) Quantitative real-time PCR analysis for RUNX-2, OCN and ALP of MSCs cultured β-TCP/Col-Hep and β-TCP/Col-HeprhBMP2 constructs after 6 weeks of subcutaneous implantation.

4. Discussion
Critical-sized bone defects typically fail to regenerate spontaneously through endogenous healing process [1].
Stem cell-based bone tissue engineering strategies are very promising approach aims to regenerate critical size
defects through integrating a triad of elements: scaffolds, growth factors, and stem/progenitor cells [20,43,44].
Many conventional approaches, including implantation of MSCs loaded on pre-fabricated scaffolds or
developing of injectable growth factors delivery systems, have been explored to address clinical challenges
[[45], [46], [47]]. However, there are still challenges in design of an ideal scaffold as the cell delivery vehicle with
controlled release of growth factors with proper anatomical geometries and physical properties to engineer new
bone tissue [10,48,49]. Researchers are investigating different approaches to utilize stem cells for bone tissue
regeneration; however, in order to harness the full potential of stem cell therapy, the scaffold should retain
stem cells at the target site after implantation as well as preserve the critical characteristics of stem cells such as
self-renewal and support them to differentiate [10,50,51].
In this article, a combinatorial approach consisting synthesis of a BMP2 immobilized collagen-heparin matrix
supported by a 3D printed bioactive ceramic scaffold was proposed to efficiently deliver MSCs. In the proposed
methodology, collagen 3D matrix was functionalized with heparin to immobilize rhBMP2 to offer a
3D microenvironment for harnessing osteogenic capacity of MSCs. Furthermore, the
supportive bioceramic scaffold play the essential roles of reinforcing and forming the biomimetic gel into desired
scaffold constructs.

Additive manufacturing techniques offer customized scaffold fabrication from a computer aided design for
patient-specific defects. 3D printing offers great control over scaffold microstructure, minimal contamination
from added material, and direct fabrication of ceramic biomaterials with high geometric complexity [4,5].
However, this approach like conventional prefabricated scaffolds suffers from relatively low cell seeding
efficiency and cell retention with cell seeding-depth limitations [52]. Herein we designed a bone ECM-mimetic
3D gel matrix to in situ seed and be mechanically supported by a 3D printed reinforced porous bioceramic
scaffold. In other words, in order to tackle seeding-depth limitations and cell retention the
collagen hydrogel with encapsulated MSCs were injected into the predesigned scaffolds.
The in vitro and in vivo results detailed in this article showed the successful combination of the benefits of
heparin functionalized collagen to deliver the MSCs and immobilized the BMP2. The collagen type I is the main
constituent of natural bone ECM; however, reconstituted collagen matrix has a low mechanical property and
shows relatively high gel contraction. To overcome contraction shortcoming of collagen gel and provide the
availability of BMP2, the collagen matrix was modified through chemical functionalization with heparin (Hep) to
immobilize rhBMP2. In order to achieve efficient binding domains into the collagen matrix, the carboxyl
groups of Hep was activated via carbodiimide chemistry prior to reaction with collagen chains. It was
demonstrated that the chemical functionalization of activated Hep onto collagen chains prior
to polymerization provides proper localization of the GAG moieties for efficient immobilization of rhBMP2.
Further, we found that such an ECM-mimetic approach also offers significantly reduced contraction of collagen
matrix, while improving its viscoelastic features. Col matrix is composed of evenly distributed fibrils, whereas
fibrillar associations were found to become locally interlocked after inclusion of heparin into the Col-Hep matrix.
Besides covalent bonds, the structural stability of Hep in collagen matrix depends on other interactions including
electrostatic, hydrophobic, and hydrogen bonds contributing to the integrity of collagen suprastructure. As
discussed below, these interactions reduce the collagen matrix contraction, which is vital to provide a robust 3D
culture microenvironment for the encapsulated cells.
The significantly lower contraction of Col-Hep compared to the Col matrices originates from the associations
developed into the Col fibrillar network through incorporated Hep chains with active carboxyl moieties (refer to
discussions related to improved viscoelastic features of Col matrix after inclusion of Hep chains). The
mechanisms behind lower contraction of cell-laden Col-Hep matrices can be described based on the changes
in collagen fibril polymerization and organization in the presence of heparin. In the course of Col matrix
gelification, the collagen fibrils gradually surround the cells. During such process, one or more collagen chains
can bond to the cell surface, followed by their reorganization in microdomains adjacent to the cells. Such
molecular reorganizations in the vicinity of cells occur through cytoskeleton-dependent rearrangement of actin
filaments [56]. Subsequently, intermolecular associations among collagen fibrils are stabilized through intra- and
intermolecular noncovalent interactions along with Col-Hep covalent bindings. It can be inferred that such
interlocked microdomains have preserved the integrity of the Col-Hep matrix over time against cellular
mechanical forces and enzymatic activities. These findings resemble the remarkable amount of heparin found in
fibrous tissues and scars, which has been understood to interrupt the ability of fibroblasts to remodel the
synthesized collagenous matrix [57].
Thermal denaturation of collagen fibrils take place due to molecular conformational changes triggered by
cleavage of intermolecular bonds including glycosylation of lysine, hydroxylysine residues and disulfide bonds
[53]. Hence, the postponed denaturation onset and peak temperatures for Col-Hep matrix implies that the
Hep conjugation has hindered fragmentation of the collagen chains through formation of crosslinks which
stabilize the fibrillar ultrastructure [54].
The rheological properties of Col-Hep matrices were also studied to find the effect of Hep to direct the
intermolecular crosslinks among collagen chains. It should be noted that the relative higher elasticity of the Col

matrix after inclusion of FreeHep relies on the possible interactions among Hep and collagen chains including
electrostatic, hydrophobic and hydrogen bonds. The Col-Hep matrix showed significantly improved elasticity.
This finding confirms an important role for Hep chains with activated carboxyl groups to chemically bond into
collagen chains and form bridges among fibrillar structures to strengthen the Col-Hep network. It is worth to
note that such covalent bonds are also responsible for the stabilization of the Col-Hep matrix beyond
gelification, and eliminate the syneresis effect as well. Such interactions in Col-Hep result in considerably
reduced matrix contraction. The sharp increase in complex viscosity for Col-Hep matrix is associated with
collagen fibril formation along with intermolecular conjugation of Hep chains. In other words, multi-site covalent
bonds among collagen and preactivated Hep chains play a predominant role in the Col-Hep matrix strength.
The higher elasticity of Col-Hep compared with Col matrix originates from intermolecular crosslinking among
Hep comprising activated carboxyl moieties with amine groups on collagen chains. In contrast to Col-Hep matrix
which showed increasing network elasticity over time, the observed decrease in complex viscosity and elasticity
of Col and Col/FreeHep matrices after an initial increase could be attributed to the syneresis effect.
Furthermore, the drop-in elasticity of the networks at elevated temperature range is due to conformational
change of collagen chains along with screening of the hydrogen bonded water molecules stabilizing them. It
should be noted that although activated Hep chains have effectively contributed to an increase in elasticity of
the Col matrix, they could not postpone disintegration of the network. Accordingly, it is inferred that the Hep
chains are locally conjugated to the collagen fibrillar network and are not percolated due to limited incorporated
Hep content (50 mg ml−1), which was intended to prohibit macro phase separation while maintaining proper
handling of the Col-based matrix.
To study the gelation behavior, the temperature sweeps multi-frequency plot of damping factor for the
neutralized Col and Col-Hep solutions does not show gelation behavior. Indeed, the observed gelification for
such systems is due to the temperature induced association of self-assembled collagen chains into fibrillar
structures. At the physiological pH (7.4) and temperature (37 °C), collagen chains undergo axial alignment and
connectivity among neighboring collagen triple helices is established [55]. The damping factor was found to be
lower for Col-Hep in comparison with Col matrix in the course of temperature triggered gelification process. This
implies interfibrillar connectivity and percolation of the collagen fibrils which have been facilitated in the
presence of Hep chains.
Several animal and clinical studies have confirmed that delivery of MSCs embedded in scaffolds in the presence
of osteoinductive growth factors results in higher bone healing compared to cell delivery alone. Bone
morphogenic proteins (BMPs) are the most osteoinductive growth factors; however, their clinical administration
has been limited by their short half-life, rapid distribution by body fluids and large doses required [24,27].
Although BMP2 delivery using various carrier systems especially polymeric materials has been shown in several
pre-clinical and clinical studies, it is still challenging to succeed a controlled introduction of BMP2 while
preserving its bioactivity and reducing the applied quantity of growth factors. Therefore, in this study we
intended to develop a bone-engineered hybrid constructs with consistent osteogenic ability to accommodate
MSCs with the capability of providing spatiotemporal bioavailability of rhBMP2.
Considering the rapid release of biomacromolecules including growth factors from gel-like matrices [56,57], we
have synthesized a collagen based matrix modified with heparin moieties to achieve sustained release of
rhBMP2. In fact, the conjugation of Hep moieties enhances the affinity of Col matrix to achieve enhanced
controlled release of rhBMP2. The electrostatic interactions between positively charged amino groups of
rhBMP2 and negatively charged sulfate groups in heparin, in addition to the strong binding of the Nterminal segments in BMP2 to heparin provides its retention and sustained release [26]. Heparin chains are
known to possess higher negative charge density compared to other biomacromolecules comprising sulfate and
carboxyl groups [58]. Further, it has been found that in the presence of heparin, degradation of rhBMP2 can be

inhibited by reducing interaction with its noggin [59]. Thus, the rhBMP2 activity is prolonged in the presence of
heparin. Consistent with our study, Lin et al. showed BMP2 immobilized in heparin-crosslinked demineralized
bone matrix increase the APase activity and calcification [60].
The binding of BMP‐2 to its receptors on MSCs is of high fundamental and clinical interest. which provokes the
MSCs differentiation into osteoblasts [61]. Our alkaline phosphatase and qPCR results obtained after in
vitro culturing of the MSCs and subcutaneous implantation of the scaffolds showed that the addition of BMP2
specially in the form of immobilization leads to a significant increase in RNA expression toward osteogenesis.
The qPCR assessment was used to analyze the gene expression levels of terminal osteogenesis related markers.
The qPCR analysis showed that the mRNA expression of RUNX-2, OCN and ALP were significantly higher in the
immobilized rhBMP2 group after 7 and 14 days. Our results are consisting with other published article on
positive effects of BMP2 immobilization. In rat ectopic model, Chen et al. [62] showed that treatment with
immobilized BMP2 resulted in upregulation of osteogenic markers including Runx2 OPN and ALP. Our results
on in vitro and in vivo characterization of Col-Hep-rhBMP2 matrices encapsulating MSCs supported by 3D
printed β-TCP scaffolds suggest that the implemented methodology provide promising integration of growth
factors and stem cells toward personalized engineering of bone tissue.

5. Conclusion
Current study presents a combinatorial bone tissue engineering strategy to develop an ECM-mimetic 3D gel to
enhance the seeding efficiency and osteogenesis activity of MSCs trough 3D printed scaffolds. The developed
constructs were consisted of heparin conjugated collagen hydrogel immobilizing BMP2, which was reinforced by
3D printed β-TCP-based bioceramic scaffold. Rheological characterizations of heparin-conjugated collagen
gel revealed their improved elasticity while suppressing the matrix contraction over time. The obtained results
revealed the great capability of heparin functionalized collagen to retain the bioactivity of growth factors and
support MSCs viability and differentiation toward bone regeneration. The in vivo histology and real-time
polymerase chain reaction (qPCR) analysis showed that the designed construct supported the osteogenic
differentiation of MSCs and induced the ectopic bone formation in the rat model. It is worth to note that the
proposed methodology can be established to integrate other osteogenic cells and growth factors for patientspecific regenerative medicine applications.
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